Literature DB >> 16617932

Primary vitamin D deficiency in adults.

.   

Abstract

In adults, prolonged deficiency of vitamin D (calciferol) can lead to osteomalacia, while lesser deficiency (insufficiency) is associated with various non-specific symptoms. Both vitamin D deficiency and insufficiency are becoming more common in developed countries. In the UK, the prevalence of vitamin D deficiency in all adults is around 14.5%, and may be more than 30% in those over 65 years old and as high as 94% in otherwise healthy south Asian adults. By comparison, the prevalence of vitamin D insufficiency in adults may be as high as 55%, and the condition is even more common in patients with osteoporotic fractures. Recently, we discussed the management of children with primary vitamin D deficiency. Here we review the management of adults with the condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617932     DOI: 10.1136/dtb.2006.44425

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  6 in total

1.  Vitamin D deficiency.

Authors:  Sally Hull
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

Review 2.  Not enough vitamin D: health consequences for Canadians.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

3.  [Metabolic bone diseases].

Authors:  F Jakob
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

4.  The problems of vitamin d insufficiency in older people.

Authors:  Barbara J Boucher
Journal:  Aging Dis       Date:  2012-06-06       Impact factor: 6.745

Review 5.  Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK.

Authors:  Sally Hayward; Rosalind M Harding; Helen McShane; Rachel Tanner
Journal:  F1000Res       Date:  2018-04-13

6.  Vitamin D status of clinical practice populations at higher latitudes: analysis and applications.

Authors:  Stephen J Genuis; Gerry K Schwalfenberg; Michelle N Hiltz; Sharon A Vaselenak
Journal:  Int J Environ Res Public Health       Date:  2009-01-07       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.